ABHD5 and lung cancer: Interestingly, among the total of five cancer types available in the database, we found that high ABHD5 expression significantly correlates with extended patient survival in four cancer types, including lung cancer (HR = 0.72, log-rank p = 2.4e-07), gastric cancer (HR = 0.77, log-rank p = 0.0054), liver cancer (HR = 0.68, log-rank p = 0,028), and ovarian cancer (HR = 0.76, log-rank p = 1.5e-05) (Fig. 7).